Log In Get Started
Press Releases April 14, 2026 04:15 PM

VALHI ANNOUNCES EXPECTED FIRST QUARTER 2026 EARNINGS RELEASE DATE

Valhi, Inc. announces expected Q1 2026 earnings release date for May 7, 2026

By Hana Yamamoto VHI
VALHI ANNOUNCES EXPECTED FIRST QUARTER 2026 EARNINGS RELEASE DATE
VHI

Valhi, Inc., a diversified company engaged in chemicals, component products, and real estate management, announced that it expects to release its first quarter 2026 earnings after market close on May 7, 2026, pending completion of quarter-end closing procedures.

Key Points

  • Valhi operates in multiple sectors: chemicals (TiO2), component products (security and marine components), and real estate development.
  • The company provides a clear earnings release schedule moving forward with expected Q1 2026 results on May 7, 2026.
  • Earnings report timing aligns with typical quarterly disclosures, allowing investors to prepare for updated financial results.

Dallas, Texas, April 14, 2026 (GLOBE NEWSWIRE) -- Valhi, Inc. (NYSE:  VHI) announced today that, subject to the completion of quarter-end closing procedures, it expects to report first quarter 2026 earnings in a press release after market close on Thursday, May 7, 2026. 

Valhi, Inc. is engaged in the chemicals (TiO2), component products (security products and recreational marine components) and real estate management and development industries.

* * *

Investor Relations Contact

Bryan A. Hanley
Senior Vice President and Treasurer
Tel. 972-233-1700


Risks

  • Potential risks related to any volatility in the chemical and component product markets which can impact Valhi’s earnings.
  • Uncertainties around the timing and content of the earnings report might affect investor expectations until release.
  • Economic conditions affecting the real estate management and development sectors could influence the company’s overall financial performance.

More from Press Releases

Fiverr Announces First Quarter 2026 Results Apr 29, 2026 Nayax to Report 2026 Q1 Earnings on May 12, 2026 Apr 28, 2026 Xunlei Filed Its Annual Report on Form 20-F for Fiscal Year 2025 Apr 28, 2026 Mesoblast Achieves Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain Apr 28, 2026 Syntec Optics (Nasdaq: OPTX) Announces Pricing of $20 Million Underwritten Public Offering of Common Stock Apr 28, 2026